Duality of iron (III) doped nano hydroxyapatite in triple negative breast cancer monitoring and as a drug-free therapeutic agent
Source abstract
Abstract
Abstract All types of cancer, due to their high mortality rates, need new methods to obtain more accurate diagnosis and more efficient treatments. In response to this need, theranostic systems have emerged as simpler and more compact agents for cancer control, comprising a synergistic effect between both diagnostic and therapeutic features into one singular system. However, such simplicity depends on the type of materials and their physicochemical characteristics. In the present work, magnetic hydroxyapatite nanoparticles were produced by chemically doping hydroxyapatite nanoparticles with 10% iron (III) ions. This material was characterized in terms of its physicochemical properties, with emphasis on its magnetic features, and biological response in terms of in vitro toxicity evaluation, using human triple negative breast cancer cell lines, and comparing the results with those produced with non-doped hydroxyapatite nanoparticles. The obtained nanoparticles had a round shape and the chemical structure of hydroxyapatite. As expected, iron ions inclusion did not influence the general chemical composition of hydroxyapatite, neither its common hexagonal crystalline structure. However, it provided the material with a superparamagnetic behaviour and a saturation magnetization of 0.5 emu/g. Additionally, these nanoparticles created high contrast effects on magnetic resonance imaging, being adequate contrast agents for cancer diagnosis. Moreover, in terms of therapy, these nanoparticles proved to be toxic to cancer cells, inducing damage on both mitochondria and cell membrane, due to calcium and iron ions release, indicating that iron plays a major role in the overall dual functionality of these nanoparticles. Such findings are a novelty since this dual functionally, in this material, was never reported, serving as a foundation for further studies in order to create a full product for cancer theranostics.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Bone Tissue Engineering Materials · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Molecular mechanisms and emerging therapeutic targets of triple-negative breast cancer metastasis10.3389/fonc.2018.00031 ↗
2. Practical approach to triple-negative breast cancer10.1200/JOP.2017.022632 ↗
3. Octreotide functionalized nano-contrast agent for targeted magnetic resonance imaging10.1021/acs.biomac.6b01256 ↗
4. Delivery of curcumin by a pH-responsive chitosan mesoporous silica nanoparticles for cancer treatment, Artif. Cells
5. Biomineral nano-theranostic agent for magnetic resonance image guided, augmented radiofrequency ablation of liver tumor10.1038/s41598-017-14976-8 ↗
6. Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies10.3390/jfb10010004 ↗
7. Dendrimer functionalized magnetic nanoparticles as a promising platform for localized hyperthermia and magnetic resonance imaging diagnosis10.1002/jcp.27849 ↗
8. Combining magnetic hyperthermia and dual T1/T2 MR imaging using highly versatile iron oxide nanoparticles10.1039/C8DT04685A ↗
9. Dose-, treatment- A nd time-dependent toxicity of superparamagnetic iron oxide nanoparticles on primary rat hepatocytes10.2217/nnm-2017-0387 ↗
10. Hydroxyapatite–polymer biocomposites for bone regeneration: a review of current trends10.1002/jbm.b.33950 ↗
11. Different hydroxyapatite magnetic nanoparticles for medical imaging: its effects on hemostatic, hemolytic activity and cellular cytotoxicity10.1016/j.colsurfb.2016.06.042 ↗
12. Antimicrobial activity of hemocompatible silver doped hydroxyapatite nanoparticles synthesized by modified sol–gel technique10.1007/s13204-013-0197-x ↗
13. Synthesis and antimicrobial activity of silver-doped hydroxyapatite nanoparticles10.1155/2013/916218 ↗
14. Synthesis and characterization of 159Gd-doped hydroxyapatite nanorods for bioapplications as theranostic systems10.1016/j.matchemphys.2016.06.063 ↗
15. In vitro study of iron doped hydroxyapatite10.4236/jbpc.2013.44017 ↗
16. Intrinsically superparamagnetic Fe-hydroxyapatite nanoparticles positively influence osteoblast-like cell behaviour10.1186/1477-3155-10-32 ↗
17. Magnetic poly( -caprolactone)/iron-doped hydroxyapatite nanocomposite substrates for advanced bone tissue engineering10.1098/rsif.2012.0833 ↗
18. Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human breast cancer cells (MCF-7)10.1007/s11051-011-0712-5 ↗
19. Synthesis and optimization of colloidal hydroxyapatite nanoparticles by hydrothermal processes
20. Wet chemical synthesis of nanocrystalline hydroxyapatite flakes: effect of pH and sintering temperature on structural and morphological properties10.1098/rsos.180962 ↗
21. Hafnium-doped hydroxyapatite nanoparticles with ionizing radiation for lung cancer treatment10.1016/j.actbio.2016.04.004 ↗
22. Cytotoxicity of hydroxyapatite nanoparticles is shape and cell dependent10.1007/s00204-012-0827-1 ↗
23. Effects of physical properties of nano-sized hydroxyapatite crystals on cellular toxicity in renal epithelial cells10.1016/j.msec.2019.109807 ↗
24. Tricalcium phosphate : synthesis , properties and biomedical applications10.1016/j.actbio.2011.06.019 ↗
25. Investigation on the structural and microstructural properties of copper-doped hydroxyapatite coatings deposited using solution precursor plasma spraying10.1016/j.jeurceramsoc.2019.06.034 ↗
26. Paramagnetic iron-doped hydroxyapatite nanoparticles with improved metal sorption properties. A bioorganic substrates-mediated synthesis10.1021/am405217j ↗
27. Blood compatibility of iron-doped nanosize hydroxyapatite and its drug release10.1021/am300140q ↗
28. Magnetite nanoparticles for medical MR imaging10.1016/S1369-7021(11)70163-8 ↗
29. Nanohydroxyapatite exerts cytotoxic effects and prevents cellular proliferation and migration in glioma cells10.1093/toxsci/kfz019 ↗
30. Calcium and mitochondria in the regulation of cell death10.1016/j.bbrc.2015.01.137 ↗
31. Different inhibitory effect and mechanism of hydroxyapatite nanoparticles on normal cells and cancer cells in vitro and in vivo10.1038/srep07134 ↗
32. Mitochondria-targeted hydroxyapatite nanoparticles for selective growth inhibition of lung cancer in vitro and in vivo10.1021/acsami.6b06094 ↗
33. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)10.3402/nano.v1i0.5358 ↗
34. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress10.2147/IJN.S13244 ↗
35. Targeting ferroptosis to iron out cancer10.1016/j.ccell.2019.04.002 ↗
36. Links between iron and lipids: implications in some major human diseases10.3390/ph11040113 ↗
37. Dynamics and functions of lipid droplets10.1038/s41580-018-0085-z ↗